Validation study of clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020

Validation study of clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020 - Validation study of clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052984

Enrollment

1000

Registered

2023-12-25

Start date

2023-11-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related sclerosing cholangitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The cases of definite, probable or possible diagnoses on the basis of clinical diagnostic criteria for IgG4-SC 2020. 2. The cases of definite, probable or possible diagnoses on the basis of clinical diagnostic criteria for IgG4-SC 2012.

Exclusion criteria

Exclusion criteria: Patients who reject to participate this study

Design outcomes

Primary

Measure	Time frame
Diagnostic ability of clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020	—

Secondary

Measure	Time frame
1.Comparison of doagnostic ability between clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020 and 2012 2.Evaluationof the cases not daignosed as IgG4-related sclerosing cholangitis based on clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020	—

Countries

Japan

Contacts

Public ContactItaru Naitoh

Nagoya City University Midori Municipal Hospital Department of Gastroenterology

inaito@med.nagoya-cu.ac.jp052-892-1331

Outcome results